Market Research Logo

Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate, Liver), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), Product (Instruments, Software), End User (Reference Laboratory, Research Centers) - Forecast to 2021

Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate, Liver), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA), Product (Instruments, Software), End User (Reference Laboratory, Research Centers) - Forecast to 2021

Growing Funding for Research on Liquid Biopsy and Technological Advancements to Boost the Growth of the Liquid Biopsy Market

The liquid biopsy market is expected to reach USD 1.66 billion by 2021 from USD 0.58 billion in 2016, growing at a CAGR of 23.4% during the forecast period of 2016 to 2021. Liquid biopsy is a non-invasive alternative to invasive solid tumor biopsies; it detects biomarkers from primary tumors and from metastatic sites to ascertain genetic information about tumors.

This report segments the liquid biopsy market on the basis of cancer type, circulating biomarkers, end users, products & services, and regions.

Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, liver cancer, and other cancers (melanoma, bladder cancer, and ovarian cancer). Based on circulating biomarkers, the liquid biopsy market is segmented into circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles (EVs), and other biomarkers (circulating RNA and protein). The circulating tumor cells segment is expected to account for the largest share of the global liquid biopsy market in 2016, followed by the circulating tumor DNA segment.

Based on end user, the liquid biopsy market is classified into hospital/physician laboratories, reference laboratories, academic and research centers and other end users. The other end-users segment includes public health laboratories, pathology laboratories, and small molecular laboratories. Similarly, based on products and services, the liquid biopsy market is segmented into instruments, reagents, and services and software.

A number of factors, such as technological advancements, increasing number of new cancer cases, benefits of liquid biopsy over solid tumor biopsy, availability of funding, and growing awareness about liquid biopsy through conferences and government initiatives are driving the growth of the liquid biopsy market. However, the unclear regulatory and reimbursement scenario is one of the major factors restraining the growth of this market.

Biocept Inc. (U.S.), Myriad Genetics (U.S.), QIAGEN (Netherlands), Roche (Switzerland), Bio-Rad Laboratories Inc. (U.S.), Trovagene Inc. (U.S.), Guardant Health, Inc. (U.S.), Janssen Diagnostics, LLC (U.S.), Fraunhofer-Gesellschaft (Germany), and MDxHealth SA (U.S.) are the major players in the liquid biopsy market.

Reasons to buy this report:
From an insight perspective, this research report focuses on various levels of analysis—industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the liquid biopsy market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on products offered by the top players in the global liquid biopsy market

Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the liquid biopsy market

Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for liquid biopsy across various regions

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global liquid biopsy market

Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the liquid biopsy market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKETS SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT SCENARIO
    • FUTURE OUTLOOK
    • CONCLUSION
  • PREMIUM INSIGHTS
    • LIQUID BIOPSY: MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER
    • LIQUID BIOPSY MARKET SIZE, BY END USER, 2016 VS. 2021
    • LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2016 VS. 2021
    • LIQUID BIOPSY MARKET SIZE, BY CIRCULATING BIOMARKER, 2016 VS. 2021
    • GEOGRAPHICAL SNAPSHOT OF THE LIQUID BIOPSY MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • MARKET DRIVERS
        • Table LIQUID BIOPSY PRODUCTS LAUNCHED IN RECENT YEARS
        • Table FUNDS PROVIDED FOR LIQUID BIOPSY, 2013-2016
        • Table CONFERENCES AND AWARENESS PROGRAMS ON LIQUID BIOPSY
      • MARKET RESTRAINTS
      • MARKET OPPORTUNITIES
        • Table LIQUID BIOPSY MARKET: INORGANIC STRATEGIES (2015-16)
      • MARKET CHALLENGES
  • INDUSTRY INSIGHTS
    • INTRODUCTION
    • REGULATORY APPROVAL PROCESS
    • MAJOR ONGOING CLINICAL TRIALS IN THE LIQUID BIOPSY MARKET
      • Table LIQUID BIOPSY CLINICAL TRIALS
    • MAJOR FUNDING ACTIVITIES IN THE LIQUID BIOPSY MARKET
      • Table FUNDING IN LIQUID BIOPSY MARKET
  • LIQUID BIOPSY MARKET, BY CANCER TYPE
    • INTRODUCTION
      • Table LIQUID BIOPSY MARKET SIZE, BY CANCER TYPE, 2014-2021 (USD MILLION)
      • LUNG CANCER
        • Table GLOBAL LIQUID BIOPSY MARKET SIZE FOR LUNG CANCER, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR LUNG CANCER, BY COUNTRY, 2014-2021 (USD MILLION)
    • BREAST CANCER
      • Table IMPACT OF AGING ON BREAST CANCER DEVELOPMENT
      • Table GLOBAL LIQUID BIOPSY MARKET SIZE FOR BREAST CANCER, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR BREAST CANCER, BY COUNTRY, 2014-2021 (USD MILLION)
      • COLORECTAL CANCER
        • Table GLOBAL LIQUID BIOPSY MARKET SIZE FOR COLORECTAL CANCER, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR COLORECTAL CANCER, BY COUNTRY, 2014-2021 (USD MILLION)
      • PROSTATE CANCER
        • Table GLOBAL LIQUID BIOPSY MARKET SIZE FOR PROSTATE CANCER, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR PROSTATE CANCER, BY COUNTRY, 2014-2021 (USD MILLION)
      • LIVER CANCER
        • Table GLOBAL LIQUID BIOPSY MARKET SIZE FOR LIVER CANCER, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR LIVER CANCER, BY COUNTRY, 2014-2021 (USD MILLION)
      • OTHER CANCERS
        • Table GLOBAL LIQUID BIOPSY MARKET SIZE FOR OTHER CANCERS, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR OTHER CANCERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER
    • INTRODUCTION
      • Table LIQUID BIOPSY MARKET SIZE, BY CIRCULATING BIOMARKER, 2014-2021 (USD MILLION)
    • CIRCULATING TUMOR CELLS
      • Table LIQUID BIOPSY MARKET SIZE FOR CIRCULATING TUMOR CELLS, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR CIRCULATING TUMOR CELLS, BY COUNTRY, 2014-2021 (USD MILLION)
    • EXTRACELLULAR VESICLES
      • Table LIQUID BIOPSY MARKET SIZE FOR EXTRACELLULAR VESICLES, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR EXTRACELLULAR VESICLES, BY COUNTRY, 2014-2021 (USD MILLION)
    • CIRCULATING TUMOR DNA (CTDNA)
      • Table LIQUID BIOPSY MARKET SIZE FOR CIRCULATING TUMOR DNA, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR CIRCULATING TUMOR DNA, BY COUNTRY, 2014-2021 (USD MILLION)
    • OTHER BIOMARKERS
      • Table LIQUID BIOPSY MARKET SIZE FOR OTHER BIOMARKERS, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR OTHER BIOMARKERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • LIQUID BIOPSY MARKET, BY PRODUCTS AND SERVICES
    • INTRODUCTION
      • Table GLOBAL LIQUID BIOPSY MARKET SIZE, BY PRODUCTS & SERVICES, 2014-2021 (USD MILLION)
      • REAGENTS
        • Table GLOBAL LIQUID BIOPSY REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY REAGENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • INSTRUMENTS
      • Table GLOBAL LIQUID BIOPSY INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • SERVICES & SOFTWARE
        • Table GLOBAL LIQUID BIOPSY SERVICES & SOFTWARE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY SERVICES & SOFTWARE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • LIQUID BIOPSY MARKET, BY END USER
    • INTRODUCTION
      • Table LIQUID BIOPSY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • REFERENCE LABORATORIES
      • Table LIQUID BIOPSY MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
      • HOSPITALS AND PHYSICIAN LABORATORIES
        • Table LIQUID BIOPSY MARKET SIZE FOR HOSPITALS AND PHYSICIAN LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR HOSPITALS AND PHYSICIAN LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
      • ACADEMIC AND RESEARCH CENTERS
        • Table LIQUID BIOPSY MARKET SIZE FOR ACADEMIC AND RESEARCH CENTERS, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR ACADEMIC AND RESEARCH CENTERS, BY COUNTRY, 2014-2021 (USD MILLION)
      • OTHER END USERS
        • Table LIQUID BIOPSY MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • LIQUID BIOPSY MARKET, BY REGION
    • INTRODUCTION
      • Table LIQUID BIOPSY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE, BY TYPE OF CANCER, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE, BY CIRCULATING BIOMARKER, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: LIQUID BIOPSY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • U.S.
        • Table U.S.: LIQUID BIOPSY MARKET SIZE, BY TYPE OF CANCER, 2014-2021 (USD MILLION)
        • Table U.S.: LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table U.S.: LIQUID BIOPSY MARKET SIZE, BY CIRCULATING BIOMARKER, 2014-2021 (USD MILLION)
        • Table U.S.: LIQUID BIOPSY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • CANADA
        • Table CANADA: LIQUID BIOPSY MARKET SIZE, BY TYPE OF CANCER, 2014-2021 (USD MILLION)
        • Table CANADA: LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
        • Table CANADA: LIQUID BIOPSY MARKET SIZE, BY CIRCULATING BIOMARKER, 2014-2021 (USD MILLION)
        • Table CANADA: LIQUID BIOPSY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • EUROPE
      • Table EUROPE: LIQUID BIOPSY MARKET SIZE, BY TYPE OF CANCER, 2014-2021 (USD MILLION)
      • Table EUROPE: LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table EUROPE: LIQUID BIOPSY MARKET SIZE, BY CIRCULATING BIOMARKER, 2014-2021 (USD MILLION)
      • Table EUROPE: LIQUID BIOPSY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • ASIA-PACIFIC
      • Table ASIA-PACIFIC: LIQUID BIOPSY MARKET SIZE, BY TYPE OF CANCER, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: LIQUID BIOPSY MARKET SIZE, BY CIRCULATING BIOMARKER, 2014-2021 (USD MILLION)
      • Table ASIA-PACIFIC: LIQUID BIOPSY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: LIQUID BIOPSY MARKET SIZE, BY TYPE OF CANCER, 2014-2021 (USD MILLION)
      • Table ROW: LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
      • Table ROW: LIQUID BIOPSY MARKET SIZE, BY CIRCULATING BIOMARKER, 2014-2021 (USD MILLION)
      • Table ROW: LIQUID BIOPSY MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • COMPETITIVE SITUATION AND TRENDS
      • AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
        • Table AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013-2016
      • NEW PRODUCT LAUNCHES
        • Table NEW PRODUCT LAUNCHES, 2013-2016
      • ACQUISITIONS
        • Table ACQUISITIONS, 2013-2016
      • OTHER DEVELOPMENTS
        • Table OTHER DEVELOPMENTS, 2013-2016
  • COMPANY PROFILES
    • INTRODUCTION
    • BIOCEPT, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • QIAGEN
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • F. HOFFMANN-LA ROCHE AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BIO-RAD LABORATORIES INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MYRIAD GENETICS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • JANSSEN DIAGNOSTICS, LLC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • TR0VAGENE INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • GUARDANT HEALTH INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • FRAUNHOFER-GESELLSCHAFT
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • MDX HEALTH SA
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report